Osaic Holdings’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Osaic Holdings’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,000	Closed	-$11.2K	–	7678
2023 Q1	$11.2K	Buy	+16,000	New	+$14.7K	﹤0.01%	5917
2022 Q4	–	Sell	-1,000	Closed	-$6K	–	7592
2022 Q3	$6K	Hold	1,000	–	–	﹤0.01%	6329
2022 Q2	$4K	Buy	+1,000	New	+$3.53K	﹤0.01%	6666
2020 Q2	–	Sell	-5,925	Closed	-$128K	–	6417
2020 Q1	$128K	Buy	+5,925	New	+$134K	﹤0.01%	3272

Osaic Holdings's STSA Position: Q2 2023 in Review

Osaic Holdings sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 16,000 shares — an estimated $11.2K sold.

Osaic Holdings first reported a position in STSA in Q1 2020 and held it in 4 quarters. The position peaked at $128K in Q1 2020. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

Osaic Holdings reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Osaic Holdings sold 16,000 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $11.2K.
Osaic Holdings first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
Osaic Holdings's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $128K in Q1 2020.
0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.